Trial Profile
Quetiapine augmentation to SRIs for patients with obsessive compulsive disorder: a double-blind, placebo-controlled study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Citalopram
- Indications Obsessive-compulsive disorders
- Focus Registrational; Therapeutic Use
- Acronyms Westenberg
- Sponsors AstraZeneca
- 30 Mar 2006 New trial record.